Actelis Files S-1 for Warrant Resale Amid Nasdaq Delisting Threat

TL;DR

**Actelis is trying to clean up its cap table and stay listed, but the underlying financial weakness and reliance on warrant exercises for cash make this a high-risk play.**

AI Summary

Actelis Networks, Inc. (ASNS) filed an S-1 for the resale of up to 680,422 shares of common stock by selling stockholders, primarily issuable upon warrant exercise. The company will not receive proceeds from these sales, but will benefit from cash received upon warrant exercises. This filing follows a significant July 2025 Private Placement where ASNS raised approximately $1 million by issuing 162,602 shares of Common Stock, Series A-3 warrants for 162,602 shares, and Series A-4 Warrants for 325,204 shares, all at a purchase price of $6.15 per share. The company also recently effected a 10-for-1 reverse stock split on November 18, 2025, to address Nasdaq's listing compliance issues, as its common stock closed at $3.11 per share on December 1, 2025. ASNS is a market leader in cyber-hardened, rapid-deployment networking solutions for wide-area IoT, utilizing hybrid fiber and existing copper/coaxial lines to offer cost-effective and secure connectivity, with a recent strategic shift from Telcos to federal, DoD, and IoT markets since 2024. The company faces ongoing challenges with Nasdaq listing compliance, having received a delist determination letter on March 27, 2024, for failing to maintain a minimum of $2,500,000 in shareholders' equity.

Why It Matters

This S-1 filing signals Actelis's efforts to facilitate liquidity for investors from its July 2025 private placement, but the company itself will not directly raise capital from these resales, only from warrant exercises. For investors, the 10-for-1 reverse stock split on November 18, 2025, and the ongoing Nasdaq delisting threat due to insufficient shareholders' equity ($2,500,000 minimum) are critical concerns, indicating significant financial instability. The strategic pivot to federal, DoD, and IoT markets from traditional Telcos, alongside its cyber-hardened hybrid fiber solutions, positions Actelis in a competitive, high-growth sector, but execution and financial health remain paramount for market confidence.

Risk Assessment

Risk Level: high — The company explicitly states, "Investing in our securities involves a high degree of risk." This is evidenced by the ongoing Nasdaq delisting threat for failing to maintain a minimum of $2,500,000 in shareholders' equity, and the recent 10-for-1 reverse stock split on November 18, 2025, often a sign of a company struggling to maintain its share price and exchange listing.

Analyst Insight

Investors should exercise extreme caution and thoroughly review Actelis's full financial statements, particularly its shareholder equity position, before considering any investment. The company's ability to regain and maintain Nasdaq compliance is a critical near-term hurdle, and the reverse stock split may not be a sustainable solution without fundamental business improvements.

Key Numbers

• 680,422 — Shares of Common Stock (Maximum shares offered for resale by selling stockholders)
• $3.11 — Closing Stock Price (ASNS closing price on Nasdaq Capital Market on December 1, 2025)
• 10-for-1 — Reverse Share Split Ratio (Effected on November 18, 2025, to address Nasdaq compliance)
• $1 million — Gross Proceeds (Raised from the July 2025 Private Placement)
• 162,602 — Shares of Common Stock (Sold in the July 2025 Private Placement)
• 162,602 — Series A-3 Warrants (Shares purchasable via Series A-3 Warrants from July 2025 Private Placement)
• 325,204 — Series A-4 Warrants (Shares purchasable via Series A-4 Warrants from July 2025 Private Placement)
• $6.15 — Purchase/Exercise Price (Per share for July 2025 Private Placement and related warrants)
• 7.0% — Placement Agent Fee (Cash fee percentage of gross proceeds from July 2025 Private Placement)
• $2,500,000 — Minimum Shareholders' Equity (Nasdaq requirement ASNS failed to meet, leading to delisting threat)

Key Players & Entities

• Actelis Networks, Inc. (company) — Registrant and issuer of securities
• Tuvia Barlev (person) — Chief Executive Officer and Chairman of the Board of Directors
• Eyal Peled, Esq. (person) — Legal counsel from Greenberg Traurig LLP
• Greenberg Traurig LLP (company) — Legal counsel for the Registrant
• H.C. Wainwright & Co., LLC (company) — Placement Agent for the July 2025 Private Placement
• Nasdaq Capital Market (regulator) — Exchange where ASNS common stock is traded
• $3.11 (dollar_amount) — Closing price of ASNS common stock on December 1, 2025
• $1 million (dollar_amount) — Total aggregate gross proceeds from July 2025 Private Placement
• $6.15 (dollar_amount) — Purchase price per share and exercise price for warrants in July 2025 Private Placement
• $2,500,000 (dollar_amount) — Minimum Shareholders' Equity Requirement for Nasdaq Listing Rule 5550(b)(1)

FAQ

Risk Factors

• Nasdaq Listing Compliance [high — regulatory]: The company received a delist determination letter on March 27, 2024, for failing to maintain the minimum shareholders' equity requirement of $2,500,000. This ongoing issue poses a significant threat to the liquidity and marketability of the company's stock.
• Dependence on Warrant Exercises [medium — financial]: The S-1 filing is for the resale of shares issuable upon warrant exercise, meaning the company does not directly receive proceeds from these sales. While warrant exercises will bring cash to the company, the overall financial health is heavily influenced by the timing and volume of these exercises.
• Competitive Market Landscape [medium — market]: Actelis operates in the competitive networking solutions market, particularly for wide-area IoT. The company's strategic shift to federal, DoD, and IoT markets since 2024 indicates a response to market dynamics and competition from established players.
• Reverse Stock Split Impact [medium — operational]: A 10-for-1 reverse stock split was effected on November 18, 2025, to address Nasdaq listing compliance. While intended to boost the stock price above minimum thresholds, reverse splits can sometimes be perceived negatively by investors and may not solve underlying business issues.

Industry Context

Actelis Networks operates in the specialized field of cyber-hardened, rapid-deployment networking solutions for wide-area IoT. The company leverages hybrid fiber and existing copper/coaxial lines to provide cost-effective connectivity. The industry is characterized by increasing demand for secure and reliable IoT infrastructure, particularly from government and defense sectors.

Regulatory Implications

The primary regulatory concern for Actelis is its ongoing struggle to maintain Nasdaq listing compliance, specifically the minimum shareholders' equity requirement of $2,500,000. Failure to rectify this could lead to delisting, significantly impacting stock liquidity and investor confidence.

What Investors Should Do

1. Monitor Nasdaq Compliance Status
2. Evaluate Warrant Exercise Trends
3. Assess Market Penetration in New Segments

Key Dates

• 2025-11-18: 10-for-1 Reverse Stock Split — Implemented to address Nasdaq listing compliance issues, aiming to increase the per-share stock price.
• 2025-12-01: Closing Stock Price — The stock closed at $3.11, highlighting the need for the reverse split to meet Nasdaq's minimum price requirements.
• 2025-07: Private Placement — Raised approximately $1 million by issuing shares and warrants, demonstrating recent capital raising activity.
• 2024-03-27: Delist Determination Letter — Received from Nasdaq for failing to meet the minimum shareholders' equity requirement of $2,500,000, indicating ongoing compliance challenges.

Glossary

S-1 Filing

A registration statement filed with the U.S. Securities and Exchange Commission (SEC) by companies planning to offer securities to the public. (This filing pertains to the resale of shares by existing stockholders, not an initial public offering.)

Warrants

Securities that give the holder the right, but not the obligation, to purchase a company's stock at a predetermined price within a specified timeframe. (A significant number of shares offered in this filing are issuable upon the exercise of warrants issued in a prior private placement.)

Reverse Stock Split

A corporate action where a company reduces the number of its outstanding shares by consolidating them, typically to increase the share price. (Actelis executed a 10-for-1 reverse stock split to comply with Nasdaq's minimum share price requirements.)

Shareholders' Equity

The value of a company's assets minus its liabilities, representing the ownership stake of shareholders. (Failure to maintain a minimum of $2,500,000 in shareholders' equity is the reason for Actelis's delisting concerns.)

Year-Over-Year Comparison

This S-1 filing is primarily for the resale of shares by selling stockholders, stemming from warrant exercises, rather than a primary offering. Unlike a typical S-1 for new capital, Actelis will not receive proceeds from the majority of the shares offered. The filing follows a recent $1 million private placement and a 10-for-1 reverse stock split, indicating recent efforts to manage its financial position and Nasdaq compliance, which was a key concern highlighted by the March 27, 2024, delist determination letter.

Key Financial Figures

• $0.0001 — 2 shares of our common stock, par value $0.0001 per share, issuable upon the exercise o
• $3.11 — stock on the Nasdaq Capital Market was $3.11 per share. This prospectus gives effec
• $6.15 — f Common Stock, for a purchase price of $6.15 per share and related Common Warrants,
• $1 million — gregate gross proceeds of approximately $1 million. The July 2025 Private Placement closed
• $35,000 — ed by the Company from the Offering and $35,000 for accountable expenses to the placeme
• $7.688 — tock) at an exercise price per share of $7.688 which will be exercisable commencing on
• $2,500,000 — to our failure to maintain a minimum of $2,500,000 in shareholders’ equity (the &ldq
• $1.00 — tock to maintain a minimum bid price of $1.00 per share (the “Bid Price Rule&rd
• $1 — quo;s common stock is now trading above $1.00, we cannot guarantee that our shares
• $11.8 — f June 20, 2029 at an exercise price of $11.8 per share (ii) 99,967 warrants issued o
• $20.0 — ecember 6, 2029 at an exercise price of $20.0 per share and (iii) 199,934 warrants is

Filing Documents

• ea0267844-s1_actelis.htm (S-1) — 268KB
• ea026784401ex5-1_actelis.htm (EX-5.1) — 12KB
• ea026784401ex23-1_actelis.htm (EX-23.1) — 3KB
• ea026784401ex-fee_actelis.htm (EX-FILING FEES) — 14KB
• image_001.jpg (GRAPHIC) — 13KB
• ex5-1_001.jpg (GRAPHIC) — 8KB
• ex23-1_001.jpg (GRAPHIC) — 2KB
• 0001213900-25-117268.txt ( ) — 450KB
• ea026784401ex-fee_actelis_htm.xml (XML) — 5KB

Use of Proceeds

Use of Proceeds 9 Selling Stockholders 10 Description of Offered Securities 12 Plan of Distribution 17 Legal Matters 18 Experts 18 Where You Can Find More Information 18 Incorporation by Reference 19 i ABOUT THIS PROSPECTUS This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission (the “SEC”). The selling stockholders named in this prospectus may from time to time sell the securities described in the prospectus. You should read this prospectus together with the more detailed information regarding our company, our Common stock, and our financial statements and notes to those statements that appear elsewhere in this prospectus and any applicable prospectus supplement together with the additional information that we incorporate in this prospectus by reference, which we describe under the heading “Where You Can Find More Information.” You should rely only on the information contained in, or incorporated by reference in, this prospectus and in any accompanying prospectus supplement. We have not authorized anyone to provide you with different information from that contained in, or incorporated by reference in, this prospectus. You should not assume that the information in this prospectus or any prospectus supplement is accurate as of any date other than the date on the front of those documents or that any document incorporated by reference is accurate as of any date other than its filing date. You should not consider this prospectus to be an offer or solicitation relating to the securities in any jurisdiction in which such an offer or solicitation relating to the securities is not authorized. Furthermore, you should not consider this prospectus to be an offer or solicitation relating to the securities if the person making the offer or solicitation is not qualified to do so, or if it is unlawful for you to receive such an offer or solicitation. In this prospectus, we fr

Forward-looking statements

Forward-looking statements are based on our management’s current expectations, estimates, forecasts and projections about our business and the industry in which we operate and our management’s beliefs and assumptions, and are not guarantees of future performance or development and involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control. As a result, any or all of our forward-looking include, among other things, those listed under “Risk Factors,” Use of Discussion and Analysis of Financial Condition and Results of Operations,” “Business” and elsewhere herein or by incorporation by reference. Potential investors are urged to consider these factors carefully in evaluating the forward-looking statements. You should read thoroughly this prospectus and the documents that we refer to with the understanding that our actual future results may be materially different from and worse than what we expect. We qualify all of our forward-looking statements by these cautionary statements. The forward-looking statements included in this prospectus speak only as of the date of this prospectus. Although we believe that the expectations reflected in the forward-looking in the forward-looking statements will be achieved or will occur. Except as required by law, we assume no obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future. You should, however, review the factors and risks we describe in the reports we will file from time to time with the SEC after the date of this prospectus. See “Where You Can Find More Information.” O

View Full Filing

View this S-1 filing on SEC EDGAR